Macroaxis: Personalized Investing
Simple Personalized Investing

BRK-A AIG TRV ACE ISP World Allocation Management Music and Video 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for CELG and SGEN ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Celgene Corp.  vs   Seattle Genetics Inc.
 Compare Fundamentals  
Daily Returns (%)
SGEN   CELG   
 
Given investment horizon of 30 days, Celgene Corporation is expected to generate 0.79 times more return on investment than Seattle. However, Celgene Corporation is 1.26 times less risky than Seattle. It trades about 0.11 of its potential returns per unit of risk. Seattle Genetics Inc is currently generating about -0.12 per unit of risk. If you would invest  12,034  in Celgene Corporation on April 25, 2013 and sell it today you would earn a total of  224.00  from holding Celgene Corporation or generate 1.86% return on investment over 30 days.

Diversification

Poor diversification
Overlapping area represents amount of risk that can be diversified away by holding Celgene Corp. and Seattle Genetics Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.71
Parameters
Time Period1 Month [change]
DirectionPositive SGEN Moved Up vs CELG
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between CELG and SGEN with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between CELG and SGEN to your reader
 
Share Correlation between CELG and SGEN 
Find Opportunities
 
Predicted Return Density
 
Returns   
SGEN   CELG   

Celgene Corporation

 
    
Celgene
Performance
5
Out Of
100
Over 30
Days
95% of all equities and portfolios perform better than Celgene Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Celgene Corporation are ranked lower than 5 (%) of all global equities and portfolios over the last 30 days.
    

Match-ups for Celgene

Gilead Sciences Inc vs. Celgene Corporation
Amgen Inc vs. Celgene Corporation
Biogen Idec Inc vs. Celgene Corporation
Regeneron Pharmaceuticals Inc vs. Celgene Corporation
Alexion Pharmaceuticals Inc vs. Celgene Corporation
Vertex Pharmaceuticals Incorporated vs. Celgene Corporation
BioMarin Pharmaceutical Inc vs. Celgene Corporation
Illumina Inc vs. Celgene Corporation
Onyx Pharmaceuticals Inc vs. Celgene Corporation
  

Seattle Genetics Inc

 
    
Seattle
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Seattle Genetics Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match-ups for Seattle

Gilead Sciences Inc vs. Seattle Genetics Inc
Amgen Inc vs. Seattle Genetics Inc
Biogen Idec Inc vs. Seattle Genetics Inc
Celgene Corporation vs. Seattle Genetics Inc
Regeneron Pharmaceuticals Inc vs. Seattle Genetics Inc
Alexion Pharmaceuticals Inc vs. Seattle Genetics Inc
Vertex Pharmaceuticals Incorporated vs. Seattle Genetics Inc
BioMarin Pharmaceutical Inc vs. Seattle Genetics Inc
Illumina Inc vs. Seattle Genetics Inc
Onyx Pharmaceuticals Inc vs. Seattle Genetics Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium